Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDS).

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2008]
Descriptionii, 36 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS111878
Subjects

Portion of title Content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDS)
General noteTitle from PDF title page (viewed on Apr. 24, 2009).
General note"April 2008".
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references (p. 27-29).
Technical detailsMode of access: Internet at the FDA CBER Web site. Address as of 4/24/09: http://www.fda.gov/cber/gdlns/cmcsomcell.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:C 42

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available